Pricing Log in Create free account

Allogene Therapeutics, Inc. (ALLO) vs Eupraxia Pharmaceuticals Inc. (EPRX)

Allogene Therapeutics, Inc. and Eupraxia Pharmaceuticals Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and Eupraxia Pharmaceuticals Inc. are of similar size ($504.4M and $491.7M). Eupraxia Pharmaceuticals Inc. has the higher net margin (0.00% vs −3,517.4%) and the higher return on invested capital (0.00% vs −108.8%). Across the 13 metrics below, Eupraxia Pharmaceuticals Inc. leads on 7 and Allogene Therapeutics, Inc. on 6.

Valuation

Metric ALLO EPRX Biotechnology median
P/E n/m n/m 8.56
P/S 98.57 n/m 10.17
P/B 1.06 4.84 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 27.88 n/m 9.64
Earnings yield (47.52%) (13.93%) (29.41%)
Free cash flow yield (22.12%) (7.89%) (23.50%)

Profitability

Metric ALLO EPRX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (3,832.45%) 0.00% 0.00%
Net margin (3,517.41%) 0.00% 0.00%
Free cash flow margin (2,180.62%) 0.00% 0.00%
Return on equity (42.39%) (117.82%) (56.66%)
Return on assets (32.43%) (64.44%) (49.22%)
Return on invested capital (108.81%) 0.00% 0.00%

Growth

Metric ALLO EPRX Biotechnology median
Revenue growth (TTM) 7,613.11% — 5.64%
EPS growth (last fiscal year) 34.09% (35.53%) 30.08%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ALLO EPRX Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 10.72 16.00 4.72
Net debt to EBITDA 1.24 2.11 0.96

Dividend

Metric ALLO EPRX Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ALLO EPRX Biotechnology median
Market cap 504.42m 491.69m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack